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Disorders of carbohydrate metabolism associated with 
diabetes have long been recognized to be paralleled by 
some alteration in lipid metabolism. A 1978 study by the 
Kentucky Diabetes Commission revealed a higher rate of 
diabetes in Eastern Kentucky--6.8 per cent of the popula-
tion as opposed to a 2.2 per cent average nationally. 
Diabetes and its complications in this area was responsible 
for the majority of hospitalizations and 30 deaths per 
100,000 people. The prevalence of diabetes in Kentuckians 
aged 17 and younger is 1.6 times higher, and 2.17 times 
higher in Kentuckians aged- 17-45, than the national 
average. Lipoprotein and lipid studies of diabetics are 
of great importance since heart and vascular disease repre-
sent the most serious complication in the life of the 
diabetic. 
A diabetic group consisting of 12 outpatients whose 
age ranged from 13-19 years was involved in this study. 
Fasting blood specimens for patients were drawn on at 
least two different occasions. All patients were on 
insulin treatment and a regulated diabetic control diet. 
A control group consisted of a normal non-diabetic popu-
lation of comparable age. 
Venous blood samples were collected after overnight 
fasts, and assayed for glucose, total serum cholesterol, 
HDL cholesterol, LDL cholesterol, and serum triglycerides, 
and polyacrylarnide electrophoresis of lipoproteins. 
Total serum cholesterol was assayed according to the 
Liebermann-Buchard method. HDL cholesterol was deter-
mined using heparin-manganese precipitation, and the 
method previously described for total serum cholesterol. 
Triglycerides were assayed by an enzymatic determination 
of glycerol. LDL cholesterol was calculated according to 
the following formula: 
C 
VLDL = TG/5 
C C C 
LDL = Serum - HDL - TG/5 
Where C = concentration of cholesterol in the LDL, 
VLDL, HDL, fractions or in serum expressed 
in mg/100 ml 
TG = serum triglycerides expressed in mg/100 ml 
Glucose was assayed by the enzymatic method of Trinder. 
Lipoprotein electrophoresis was performed using a modi-
fied polyacrylamide gel technique. 
Within the diabetic group 67 per cent were found to 
be hyperlipidemic. Hyperlipidemic juveniles were classi-
fied on the basis of total cholesterol, LDL-cholesterol, 
and triglycerides as verified by polyacrylamide gel 
electrophoresis. These juveniles were classified as 
types IV, IIa, IIb in order of frequency. When diabetic 
juveniles were compared with non-diabetic juveniles, 
statistically significant elevations of total cholesterol, 
LDL-cholesterol, and a decreased HDL-cholesterol were 
observed. An increase in triglyceride was also observed 
in the diabetic population, but was not statistically 
significant. Statistical tests were based on the standard 
pooled t test. 
The diabetic group was subdivided into two groups 
based on good or poor diabetic control. The poor control 
group consisted of patients in whom only sporadic control 
was noted, however, all were outpatients at the time of 
sampling, and none were ketotic. 
The most common features in hyperlipidemic juvenile 
diabetics were an increased total cholesterol, LDL-
cholesterol, and a decreased HDL-cholesterol. Hyper-
triglyceridemia was resolved with good diabetic control, 
which is well substantiated by other studies, which 
directly related degree of control with triglyceride 
levels. Cholesterol levels, both total and lipoprotein 
fractions, showed mean differences as compared to the 
non-diabetic group, regardless of control. The higher 
mean values of total cholesterol and LDL-cholesterol, and 
the decreased HDL-cholesterol in the diabetic cases 
indicate a disturbed lipid metabolism in the diabetic 
juvenile. 
Major risk factors for the development of athero-
sclerosis seem to be prominent in diabetes mellitus, 
since hypercholesterolemia, elevated LDL-cholesterol 
fraction or a decrease1-in the HDL-cholesterol fraction 
represent a greater risk than in the non-diabetic. The 
ratios of Total Cholesterol/HDL-Cholesterol, LDL-
Cholesterol/HDL-Cholesterol, were 3.8 and 2.5 times 
higher respectively, in the diabetic juvenile when com-
pared to the non-diabetic juvenile. These ratios have 
been found to be indicators of cardiovascular risk in 
previous studies. These findings indicate an accelerated 
risk for these individuals since there is an alteration 
in lipoprotein metabolism, and possibly an alteration in 
the metabolism of the arterial walls , at an early age in 
the juvenile diabetic. 
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Disorders of carbohydrate metabolism associated with 
diabetes mellitus have long been recognized to be paral-
lelled by some alteration in lipid metabolism.17,21,22,23 
Investigators have reported elevated serum concentration 
of cholesterol and triglyceride in diabetes. 17 , 21 , 22 , 23 
The identification of hypercholesterolemia and hyper-
triglyceridemia as two of a number of coronary risk fac-
tors, and the susceptibility of diabetics to atheroscler-
osis, have directed interest toward abnormalities of lipid 
metabolism in diabetes. 23 Lipoprotein and lipid studies 
of diabetics are of great importance since heart and vas-
cular disease represent the most s~rious complication in 
the life of the diabetic. 13,17,21,22,23 
Coronary atherosclerosis is characterized by an ac-
cumulation of lipid, primarily cholesterol, in the arte-
rial wall. Evidence that this may be due, in part, to a 
filtration into the arterial intima of low density (LDL) 
lipoprotein cholesterol has been well documented.J,ll,lS,l9 
There is also evidence that the transport of cholesterol 
from the peripheral tissues to the liver for catabolism 
and excretion may be a function of plasma high-density 
lipoprotein (HDL), which also inhibits the uptake of LDL 
by the peripheral tissues. 3 , 4 , 11 , 15 ,19 This would account 
2 
for an inverse relationship between HDL and the cardio-
vascular risk. The amount of plasma HDL has been found 
to be decreased in diabetes, 15 and elevated levels of 
cholesterol and triglycerides have been reported in 25 to 
50 per cent of diabetics. 13 , 22 ,2 3 
A biochemical pathway to show how human cells gain 
access to the cholesterol esters bound to LDL has been 
proposed by Goldstein and Brown. 11 The sequential steps 
involved in this pathway are as follows: (1) Cells re-
quiring cholesterol synthesize a receptor that becomes 
localized on the cell surface. (2) LDL binds to this re-
ceptor with high affinity. (3) The bound LDL is then 
taken up by the cell via an endocytotic process. (4) The 
membrane receptor-LDL complex invaginates into the cell, 
forming an endocytic vesicle which migrates through the 
cytoplasm and fuses with a lysosome. (5) The protein of 
the LDL is hydrolyzed by lysosomal proteases to amino 
acids. (6) The cholesterol esters are hydrolyzed by a 
lysosomal acid lipase. (7) The free cholesterol produced 
passively crosses the lysosomal membrane, and gains access 
to the cellular compartment.11 
The cell suppresses its own cholesterol synthesis, 
having obtained cholesterol from LDL, by reducing the 
activity of a rate controlling microsomal enzyme, 
3-hydroxy-3-methyl glutaryl coenzyme A reductase (HMG CoA 
reductase). When excess cholesterol enters the cell 
through the LDL pathway, it is stored in the cell in the 
form of cholesterol ester droplets. The formation of 
cholesterol esters is triggered by the activation of acyl 
CoA: cholesterol acyl transfera~
1
e (ACAT) , a microsomal 
enzyme that attaches a long fatty acid to free choles-
terol.11 
3 
It has been postulated that HDL works in an opposing 
manner. Studies of the metabolism of arterial smooth 
muscle cells show that HDL binds to the surface receptor 
of smooth muscle cells as effectively as LDL, but HDL is 
degraded much more slowly. When cells were incubated with 
an equal or higher concentration of HDL, no net increment 
of cholesterol was noted. The presence of HDL in the 
medium inhibits uptake and degradation of LDL.4 
A second mechanism is proposed whereby HDL serves to 
clear cholesterol from the arterial wall. As the mert'branes 
of arterial cells exhibit biological turn over, and as 
cells die and are renewed, cholesterol is released from 
the tissues. This cholesterol binds to HDL, where it is 
converted to cholesterol esters by the enzyme lecithin-
cholesterol acyl transferase (LCAT) . 11 This form of cho-
lesterol is then returned to the liver for excretion. 
It has become increasingly apparent that the process 
of atherosclerosis has a long natural history beginning 
in early childhood. 2 The fact that hyperlipoproteinemia 
is present in a large percentage of middle-aged diabetics 
suggests that an alteration in carbohydrate metabolism of 
juvenile diabetics may also produce an observable change 
in lipid metabolism at an early age. This metabolic 
alteration may enhance the atherogenic process in these 
juveniles. The study of lipid profiles in these juve-
niles also affords a study of the atherogenic process, 
uncomplicated by other chronic disease processes fre-
quently seen in older diabetics. 
The purpose of this study was to compare triglycer-
ide, total cholesterol, HDL cholesterol and LDL choles-
terol levels in the serum of diabetic and non-diabetic 
adolescents of Eastern Kentucky. The study was also de-
signed to analyze data for the identification of factors 
of potential risk in the pathogenesis of atherosclerosis. 
A conclusion that increased risk of atherosclerosis could 
exist, would indicate that in the juvenile diabetic, 
lipid metabolism, as well as carbohydrate metabolism, 
should be monitored and controlled. 
4 
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MATERIALS AND VJETHODS 
A diabetic group consisting of 12 outpatients whose 
age ranged from 13-19 years was involved in this study. 
Blood specimens from fasting patients were obtained on at 
least two different occasions. All patients were being 
treated with insulin and a regulated diabetic diet. A 
control group consisted of a normal non-diabetic popula-
tion of comparable age. 
Venous blood samples were collected after overnight 
fasts, and assayed photometrically for glucose, total 
serum cholesterol, HDL cholesterol, LDL cholesterol and 
serum triglyceride. HDL and LDL levels were qualitated 
by polyacrylamide electrophoresis of lipoproteins. 
Blood Glucose 
Glucose was assayed by the method developed by 
Trinder. 24 Glucose is oxidized by glucose oxidase to 
gluconic acid and hydrogen peroxide. The hydrogen per-
oxide reacts in the presence of peroxidase, with phenol 
and 4-amino phenazone to form a 0-quinone imine dye which 
is measured photometrically. 
Procedure 
1. Label tubes blank, standard, control, and sample. 
2. Pipet 4.0 ml of glucose reagent (Boehringer-
Mannheim cat. no. 189197) into all cuvettes 
(13 X 100 mm) • 
3. Add 0.02 ml of sample, standard, control and 
distilled water to the respective cuvettes. 
4. Mix all tubes well and incubate at 37°C for 10 
minutes. 
5. Read absorbance of standard, control and sample 
at 540 mm. 
6. Calculate concentration of glucose as follows: 
mg glucose/100 ml= 
6 
Absorbance of unknown x concentration of std. 
Absorbance of standard 
Total Serum Cholesterol 
The Liebermann-Buchard method, as modified by Huang, 
was used for cholesterol assays. Cholesterol reacts 
strongly with sulfuric acid to produce green colored bis-
cholestadienyl-monosulfonic acids. 12 
Procedure 
1. Label tubes, standard, control, sample and reagent 
blank. 
2. Pipet exactly 3.0 ml of cholesterol reagent 
(Stanbio Laboratory Co., Dallas, Tex.) into test 
tubes. 
3. Add 0.1 ml of cholesterol standard, control, 
sample and distilled water into the appropriate 
test tube. 
4. Mix all tubes well and incubate at room tempera-
ture for 20 minutes. 
5. Read absorbance of standard, control and sample 
at 610 nm. 
6. Calculate cholesterol concentration by the fol-
lowing formula: 
mg cholesterol/100 ml= 
7 
Absorbance of unknown x Concentration of std. 
Absorbance of standard 
HDL Cholesterol 
HDL cholesterol was determined using the Liebermann-
Buchard method as described for total serum cholesterol, 
in conjunction with heparin-manganese precipitation to 
eliminate the VLDL and LDL fractions. 
Procedure 
1. Label tubes control and sample. 
2. Pipet 1.0 ml of serum and controls into test 
tubes, and add 0.1 ml of precipitating reagent 
(Stanbio Laboratory, Dallas, Tex.). 
3. Mix all tubes well, centrifuge at 3,500 rpm for 
approximately 10 minutes, then decant. 
4. Add 0.2 ml of the supernatant to 3.0 ml of 
cholesterol reagent (Stanbio Laboratory Co., 
Dallas, Tex.). 
5. Mix all tubes well and incubate at room tem-
perature for 20 minutes. 
6. Read the absorbance of the solution at 610 nm. 
7. Calculate the HDL cholesterol concentration by 
the following formula: 
8 
HDL cholesterol/100 ml= Absorbance of unknown 
mg Absorbance of standard 
x concentration of x•5 standard 
Triglyceride 
Triglyceride content was determined using an enzy-
matic method. Triglycerides are saponified in the presence 
of alcoholic potassium hydroxide to fatty acids and free 
glycerol. Glycerol then undergoes a series of coupled re-
actions, and the amount of NADH oxidized during the reac-
tion is then measured. The amount of NADH oxidized is pro-
portional to the amount of glycerol in the specimen. 
Procedure 
1. Label tubes control and sample. 
2. Pipet into a test tube 0.2 ml of sample or con-
trol and 0.5 ml alcoholic potassium hydroxide. 
3, Mix all tubes well, seal and incubate for 20-30 
minutes at between 55~70°C. 
9 
4. Allow tubes to cool to room temperature, then add 
1.0 ml of 0.15 M magnesium sulfate. Mix tubes 
and centrifuge. Decant supernatant. 
5, Add 0,5 ml of the supernatant to 2.5 ml of tri-
glyceride reagent (Boehringer-Mannheim, cat. no. 
125032) • 
6. Mix all tubes and incubate at room temperature for 
5 minutes. 
7. Measure initial absorbance (A1), at 340 or 366 nm. 
8. Add 0.2 ml of glycerokinase to all tubes and mix. 
Let all tubes stand for approximately 10 minutes, 
then read final absorbance (A2); A= A1 - A2 • 
9. Calculate triglyceride concentration according to 
the following formula: 
AX Va X MW X 8,5 
a x D x Vs x 10 = mg triglyceride/100 ml 
A = Difference in absorbance between initial 
and final readings. 
Va= Total assay volume= 3.04 ml 
MW= Average molecular wei~ht of triglycerides 
in human serum= 885. 
a = Absorbency coefficient·=3,30 cm2/µ mole 
at 366 nm. 
D = Light path= 1 cm 
Vs = Volume of the supernatant= 0.50 ml 
10 = Conversion to mg/100 ml 
8.5 = Dilution factor due to saponification and 
neutralization of specimen 
mg triglycerides/100 ml= 1386 x A 
LDL Cholesterol 
10 
LDL cholesterol was calculated according to the follow-
ing formula: 
CVLDL = TG/5 
CLDL = Cserum ~ CHDL - TG/5 
where 
C = Concentration of cholesterol in the LDL, 
VLDL, HDL fractions or in serum expressed 
in mg/100 ml 
TG=serum triglycerides expressed in mg/100 ml 
Polyacrylamide Gel Electrophoresis 
Polyacrylamide gel electrophoresis is a technique in 
which separation is dependent upon electrophoretic mobility 
and molecular size.6,l0, 15 This type of disc electro-
phoresis sharply delineates lipoprotein bands, and is the 
more rapid of the electrophoretic methods used for separa-
ting lipoproteins. The sample is prestained with Sudan 
11 
Black Bin a sample gel. It is then resolved by electro-
phoresis in a discontinuous pH system consisting of a sample 
gel, concentrating gel and separating gel. 
Reagents 
Solution A. Dissolve 36.6 g of Tris ("Trizma base," 
Sigma Chemical Co., St. Louis, Mo.) and 0.23 ml of "TEMED" 
(Eastman Organic Chemicals, Rochester, N.Y. cat. no. 8178) 
in approximately 100 ml of distilled water. Add 48 ml of 
lNHCL and dilute to 200 ml with distilled water. The pH 
should be 8.9. It is stable for three months at 4°C in a 
brown bottle. 
Solution B. Dissolve 5.98 g of Tris (Trizma base) and 
0.46 ml of TEMED in 25 ml of distilled water. Add .48 ml 
of lNHCL and dilute to 100 ml with distilled water. The 
pH should be 6.7. It is stable for three months at 4°C 
in a brown bottle. 
Solution c. Dissolve 15.0 g of acrylamide (Eastman, 
cat. no. 5521) and 0.40 g of bisacrylamide (Eastman, cat. 
no. 8383) in 75 ml of distilled water, and dilute to 100 ml 
with distilled water. It is stable for three months at 
4°C in a brown bottle. 
Solution D. Dissolve 20.0 g of acrylamide and 5.0 g 
of bisacrylamide in water and dilute to 200 ml with 
distilled water. It is stable for three months at 4°C 
in a brown bottle. 
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Solution E. Dissolve 8.0 mg of riboflavin (Sigma 
Chemical Co., St. Louis, Mo.) in 100 ml of distilled water. 
It is stable for three months at 4°C in a brown bottle. 
Solution F. Dissolve 200 g of sucrose in 400 ml of 
water and dilute to 500 ml with distilled water. 
Solution G. Dissolve 0.14 g of ammonium persulfate in 
50 ml of distilled water in a 100 ml volumetric flask, and 
dilute to volume with distilled water. It is stable for 
one week at 4°C in a brown bottle. 
Dye Solution. Add 250 mg of Sudan Black B to 30 ml 
of absolute ethanol, mix well, and dilute to 100 ml with 
distilled water. It is stable for one month at room tem-
perature in a brown bottle. 
Separating Gel Solution. Remove the desired amount of 
solutions A, C, and G from their refrigerated bottles, 
place suitable amounts in containers, and bring to room 
temperature before combining them. Combine solutions A, 
C, and Gin the ratio of 1:1:2, by volume. Prepare ap-
proximately 1.0 ml of the separating gel solution per 
separating gel required. The separating gel solution 
should be prepared just before use. 
Concentrating Gel Solution. Mix solutions B, D, E, 
and Fin the ratio of 1:2:1:4, by volume. It is stable 
for one month at 4°C in a brown bottle. 
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Sample Gel Solution. Just before use, add 8 parts of 
concentrating gel solution to 1 part of dye solution and 
mix by gentle inversion. 
Reservoir Buffer. Dissolve 6.0 g of Tris (Matherson, 
Coleman & Bell, no. 7060) and 28.8 g of glycine (Sigma) 
in about 850 ml of distilled water. If necessary, adjust 
the pH to 9.5 with Tris or glycine. Dilute to 1 liter 
with distilled water. The reservoir buffer may be used 
for 7 days (based on two runs per day). 
Equipment 
The Buchler Polyanalyst gel system and power supply 
were used for electrophoretic separations (Buchler-Cotlove 
Instruments). The Gelman densitometer· (Model DCO-16) was 
used to evaluate band migration (Gelman Instrument Co., 
Ann Arbor, Mich.). 
PYocedure 
1. Add 1.0 ml of freshly prepared separating gel 
solution to each gel tube. Carefully add water 
on top of the gel solution to prevent a curved 
meniscus from forming as the gel polymerizes. 
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The separating gel polymerizes, if undisturbed, in 
30 minutes at room temperature. (All polymeriza-
tion procedures must be performed under intense 
light.) 
2. After photopolymerization is complete, invert the 
tubes and blot on absorbent paper. 
3. Add 0.05 ml of concentrating gel solution. Layer 
the gel solution as above, and allow tubes to 
remain undisturbed for 10 minutes. 
4. After polymerization is complete, invert the tubes 
and blot on absorbent paper. 
5. Add 0.02 ml of serum and 0.1 ml of sample gel 
solution to each tube. Mix each tube by inversion 
and layer each tube with reservoir buffer. Allow 
the tubes to remain undisturbed for 20-30 minutes. 
6. Insert the tubes into the electrophoretic cell. 
Electrophoresis should be run for 25-30 minutes at 
5 rnillamperes per gel tube. 
7. Densitrometric scans are made following electro-
phoresis using a 615 nm interference filter. There 
is no need to remove the gel from the tube. If 
densitometry cannot be immediately performed, 
the tubes should be refrigerated and shielded to 
avoid color fading. 
8. Chylomicrons remain in the sample gel. VLDL are 
15 
retained near the origin of the separation gel. 
LDL migrates about half the distance of the sepa-
rating gel, and HDL is the fastest migrating 
anodic fraction, migrating to near the end of 
the tube. 
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RESULTS AND DISCUSSION 
Within the diabetic group 67 per cent were found 
to be hyperlipidemic. Hyperlipidemic juveniles were 
classified, on the basis of total cholesterol, LDL-
cholesterol and triglycerides, as lipoprotein pheno-
types IV, IIa, IIb, in order of decreasing frequency.·B 
These results were then verified, qualitatively, by 
densitometric analysis of the polyacrylamide gels. 
When diabetic juveniles were compared with non-diabetic 
juveniles, statistically significant elevations of 
total cholesterol, LDL-cholesterol, and a decreased 
HDL-cholesterol were observed (Table I). An increase 
in triglyceride was also observed in the diabetic 
population, but was not statistically significant. 
Statistical tests were based on the standard pooled 
t test. 
The diabetic group was subdivided into two groups 
based on good or poor diabetic control. The poor con-
trol group consisted of patients in whom only sporadic 
control was noted, however, all were outpatients at the 
time of sampling, and none were ketotic. Juvenile 
diabetics in good control were found to have signifi-
cantly lower triglyceride levels when compared to 
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diabetics with poor control (Table II). There were no 
statistically significant differences in HDL-cholesterol, 
total cholesterol, and LDL-cholesterol. Although the 
cholesterol and LDL-cholesterol were higher, HDL-
cholesterol was lower in the poor control-group. 
Table I 
Diabetic Juveniles vs. Non-'Diabetic Juveniles 
Glucose 
(mg/100 ml) + S.D. 
Triglyceride 
(mg/100 ml)± S.D. 
Total Cholesterol 
(mg/100 ml)± S.D. 
HDL-Cholesterol 
(mg/100 ml) ± S.D. 
LDL-Cholesterol 
(mg/100 ml) + S.D. 
Non-Diabetic Group 
90 + 14.3 
----
132 + 34.B 
161 + 26.4 
---
46 + 8.1 
91 + 20.3 
- --
Diabetic Group 
254 + 124.3 
---
145 + 68. l 
224 + 44.l 
-
33 + 9.4 
162 + 42.5 
- -
Statistical tests are based on standard pooled t test 
(p < 0.05), where n = 12 for non-diabetic group and 
n = 12 for diabetic group. Significant deviations are 
underscored. 
Table II 
Good Control Diabetic Juveniles vs. Poor 
Control Diabetic Juveniles 
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Good Control Poor Control 
Glucose 129 + 14.5 342 + 78 (mg/100 ml) + S .D. ---
Triglyceride 87 + 21.5 186 + 58.3 (mg/100 ml) + S.D. 
-
Total Cholesterol 205 + 37.8 238 + 46.3 (mg/100 ml) + S.D. -
HDL-Cholesterol 31 + 6.5 34 + 6.8 (mg/100 ml) + S.D. 
LDL-Cholesterol 144 + 44.6 166 + 44.9 (mg/100 ml) + S.D. 
Statistical tests are based on standard pooled t test 
(p < 0.05) where n = 5 for good control diabetics and 
n = 7 for poor control diabetics. Significant devia-
tions are underscored. 
Statistical comparison of good control diabetics 
with the non-diabetic population illustrated that while 
control does lower the triglyceride levels, triglyceride 
levels were statistically significantly lower in the 
diabetic group than in the non-diabetic group. However, 
both were within normally used clinical limits. This is 
19 
in agreement with the lipid study by Wille.22 LDL-
cholesterol levels were still significantly higher, and 
HDL-cholesterol levels were significantly lower for 
juveniles of the same age (Table III). 
Table III 
Good Control Juvenile Diabetics vs. Non-
Diabetic Juvenile Group 
Good Control Non-Diabetic 
Glucose 
(mg/100 ml) + S.D. 
Triglyceride 
(mg/100 ml)~ S.D. 
Total Cholesterol 
(mg/100 ml)~ S.D. 
HDL-Cholesterol 
(mg/100 ml) + S.D. 
LDL-Cholesterol 
(mg/100 ml) + S.D. 
Diabetics 
129 + 14.5 
-
87 + 21.5 
205 + 37.8 
31 + 6.5 
144 + 44.6 
---
Control 
90 + 14.3 
132 + 34.8 
---
161 + 26.4 
46 + 8.1 
91 + 20. 3 
Statistical tests are based on standard pooled t test 
(p < 0.05) where n = 5 for good control diabetics, and 
n = 12 for non-diabetic control. Significant deviations 
are underscored. 
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When poorly controlled diabetics were compared with 
the non-diabetic controls, total cholesterol, trigly-
ceride and LDL-cholesterol levels were also significantly 
different (Table IV). HDL-cholesterol levels were again 
observed to be significantly decreased. 
Table IV 
Poor Control Diabetic Juveniles vs. Non-
Diabetic Control Juveniles 
Poor Con"(::rol Non-Diabetic 
Glucose 
(mg/100 ml)~ S.D. 
Triglyceride 
(mg/100 ml) ~ S.D. 
Total Cholesterol 
(mg/100 ml)~ S.D. 
HDL-Cholesterol 
(mg/100 ml) ~ S.D. 
LDL-Cholesterol 
(mg/100 ml) + S.D. 
Diabetics 
342 + 78 
186 + 58.3 
238 + 46.3 
---
34 + 6.8 
-
166 + 44.9 
---
Controls 
90 + 14.3 
132 + 34.8 
161 + 26.4 
46 + 8.1 
91'+ 20.3 
Statistical tests are based on standard pooled t test 
(p < 0.05) where n = 7 for poor control diabetics, and 
n = 12 for non-diabetic controls. Significant devia-
tions are underscored. 
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Age, sex, age at onset and duration of disease were 
found to be non-significant factors in hyperlipidemic 
patients. All patients used in this study were not hyper-
tensive, and the diabetic patients were treated with 
insulin and a regulated diet alone at the time of sampling. 
The most common features in hyperlipidemic juvenile 
diabetics were an increased total cholesterol and LDL-
cholesterol levels, and a decreased HDL-cholesterol. 
Hypertriglyceridemia was resolved with good diabetic con-
trol. This observation is in agreement with other 
studies which also directly related degree of diabetic 
control with triglyceride levels. 1 , 5 , 13 ,l4, 22 , 23 
Cholesterol levels, both total and lipoprotein fractions, 
showed mean differences when compared to the non-diabetic 
group, regardless of control. The higher mean values of 
total cholesterol and LDL-cholesterol, and the decreased 
HDL-cholesterol in the diabetic cases indicate a dis-
turbance of the normal lipid metabolism in the diabetic 
juvenile. 
Major risk factors for the development of athero-
sclerosis seem to be prominent in diabetes mellitus, since 
hypercholesterolemia, elevated LDL-cholesterol fraction 
or a decrease in the HDL-cholesterol fraction represent a 
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greater risk than in the non-diabetic.21 The ratios of 
total cholesterol/HDL-cholesterol and LDL-cholesterol/ 
HDL-cholesterol were 2.0 and 2.5 times higher respectively 
in the diabetic juvenile than in the non-diabetic 
juvenile. •· These ratios have been found to be indicators 
of cardiovascular risk in previous studies.B These 
results suggest an accelerated risk for diabetic juve-
niles since there is an alteration in lipoprotein meta-
bolism, and probably an alteration of the'm~tabolism in' 
the arterial walls, which is initiated at an early age in 
·the juvenile diabetic.19 
Therefore, in the juvenile diabetic, even those 
diabetics exhibiting controlled blood glucose, there are 
prominent lipid and lipoprotein levels that elevate the 
risk of cardiovascular disease. The total cholesterol, 
LDL-cholesterol, HDL-cholesterol and triglyceride levels 
should be monitored, even in the diabetic with controlled 
blood glucose levels. 
23 
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